Parabilis Medicines is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them.
- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 145
- Founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015
- Formerly known as Fog Pharma
- Headquartered in Cambridge, Massachusetts
- https://parabilismed.com/
No comments:
Post a Comment